Welcome to Grünenthal's Press Centre
The Grünenthal Group is an independent, family-owned international research based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company to be a leader in therapy innovation. Grünenthal sustainably invests in re-search and development. These investments amounted to 20 % of revenues in 2014.
You’d like to know more about Grünenthal?
If you have any further questions, please do not hesitate to contact us.